Govt Leadership Needed to Promote Industry Reorganization, Strengthen Competitiveness: Former JPMA President Aoki

Hatsuo Aoki The arrival of an “80% generic” era will force research-driven drug makers to invest even more of their management resources into R&D. Jiho asked Hatsuo Aoki, who served as president of the Japan Pharmaceutical Manufacturers Association (JPMA) from...read more